Successful surgical treatment of cardiac complication of graves disease

Jooncheol Min1, Woong-Han Kim1, Woo Sung Jang1

  • 1Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Korea.

Insights

Graves disease can cause serious heart problems like arrhythmia and heart failure. Prompt hyperthyroidism treatment is crucial, as cardiac issues may become irreversible if delayed.

Area of Science:

  • Cardiology
  • Endocrinology
  • Thyroidology

Background:

  • Graves disease is an autoimmune disorder leading to hyperthyroidism.
  • Hyperthyroidism can cause significant cardiac complications, including arrhythmia and heart failure.
  • These cardiac issues are often reversible with timely medical management of thyroid dysfunction.

Observation:

  • A case is presented where cardiac complications of Graves disease were severe.
  • The patient's cardiac condition progressed despite medical treatment for hyperthyroidism.
  • The severity of the cardiac complication necessitated surgical intervention.

Findings:

  • Delayed diagnosis or treatment of hyperthyroidism in Graves disease can lead to irreversible cardiac damage.
  • In advanced cases, medical management alone may be insufficient to reverse cardiac complications.
  • Surgical treatment may be required when medical therapy fails to restore cardiac function.

Implications:

  • Highlights the critical importance of early detection and management of Graves disease to prevent severe cardiac sequelae.
  • Underscores the potential for cardiac complications to become refractory to medical treatment.
  • Suggests a need for vigilant cardiac monitoring in patients with Graves disease, especially those with delayed or inadequate treatment.

Related Concept Videos

Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
13
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
14
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
583
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
454
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
743
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.9K